{"url_path":"/sec/derm/8-k/2026-05-13/item-2-02","section_key":"item-2-02","section_title":"Item 2.02 ****Results of Operations and Financial Condition.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1867066/0001104659-26-060232-index.html","accession_number":"0001104659-26-060232","cik":"0001867066","ticker":"DERM","issuer_name":"Journey Medical Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/1867066/0001104659-26-060232-index.html","primary_entity_key":"0001867066","primary_entity_name":"Journey Medical Corp"},"word_count":130,"has_tables":true,"body_markdown":"**Item 2.02.****Results of Operations and Financial Condition.**\n\n \n\nOn May 13, 2026, Journey\nMedical Corporation issued a press release to provide a corporate update and to announce its financial results for the three months ended\nMarch 31, 2026. A copy of such press release is being furnished as Exhibit 99.1 to this report.\n\n \n\nThe information, including\nExhibit 99.1, in this Form 8-K is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities\nExchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Form 8-K shall not\nbe incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall otherwise be expressly set\nforth by specific reference in such filing."}